XML 34 R16.htm IDEA: XBRL DOCUMENT v3.24.4
Revenues
 3 Months Ended
Nov. 30, 2024
Revenues  
Revenues

10. Revenues

 

A breakdown of our revenues by type for the three-months ended November 30, 2024, and November 30, 2023, are as follows:

 

 

 

Three-Months Ended November 30

 

 

 

2024

 

 

2023

 

 

 

 

 

 

 

 

IP Licensing

 

$174,000

 

 

$144,990

 

B2B

 

 

9,923

 

 

 

5,388

 

Other

 

 

-

 

 

 

900

 

 

 

$183,923

 

 

$151,278

 

 

During the three-month period ended November 30, 2024, and 2023, the Company recognized B2B product revenues of $9,923 and $5,388, respectively, that relate to sales of our intermediate products for use by B2B customers in their products. Licensing revenue consists of IP licensing fees for transfer of the DehydraTECH technology in line with definitive agreements and includes non-refundable minimum performance fees. The Company recognized $174,000 and $144,990 in licensing revenue in the three-months ended November 30, 2024, and 2023, respectively.